Prostate Carcinoma — Trials

Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,176 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 230
Ph III recruiting: 20
Growth YoY: −2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (184)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04549207	Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer	active not recruiting	Phase 4	240	Ottawa Hospital Research InstituteOTHER	1	Jul 21, 2026	clinicaltrials
NCT06733350	Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance	recruiting	Phase 4	600	Roswell Park Cancer InstituteOTHER	1